New resources to support the implementation of biosimilars in ophthalmology
Following publication of the wet age-related macular degeneration (wAMD) pathway, NHS England has published new commissioning guidance regarding treatment pathways in macular oedema secondary to retinal vein occlusion (RVO). Members are encouraged to visit the NHS Futures Biosimilar Hub in order to view the guidance.